Djamgoz, Mustafa B. A. https://orcid.org/0000-0003-1435-8540
Article History
Accepted: 21 October 2024
First Online: 12 November 2024
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: MBAD sits on the Scientific Advisory Board of the company Onkim (which aims to develop stem cell technologies) and holds shares in Celex Oncology Innovations Ltd (which aims to develop ion channel drugs against cancer).